News

Sun Pharma Advanced Research Company secures a favourable tribunal ruling for refund of accumulated CENVAT credit worth Rs 27.51 crore along with applicable interest. 

Sun Pharma Advanced Research Wins Rs 27.51 Crore CENVAT Credit Refund Dispute, Tribunal Dismisses Revenue's Appeal

Judgement

The ITAT Ahmedabad held that revenue must establish specific nexus between accommodation-entry provider and assessee’s sales transactions.


ITAT Remits Rs. 1.80 Crore Section 68 Addition for Fresh Verification of Accommodation Entries

The ITAT dismisses revenue appeal on low tax effect in Section 69B read with Section 115BBE dispute.


ITAT Rules CBDT Monetary Limit of Rs.60 Lakh Applies Where Section 115BBE Is Inapplicable to Business Income

The ITAT Delhi rules tax claims not forming part of approved resolution plan stand extinguished under IBC.

ITAT Dismisses Revenue and Assessee Appeals in Sahara Airlines Tax Dispute After IBC Proceedings

The ITAT Delhi has Quashed assessment as Time-Barred where limitation ran from transfer of Assessee’s case under Section 127.

ITAT Dismisses Revenue Appeal in Section 153C Limitation Dispute

The ITAT holds Assessment Year 2011-12 beyond permissible Ten-Year block period under Section 153C.

Explore Our Blogs

Stay updated with the latest insights, tips, and industry trends from our experts

Sun Pharma Advanced Research Wins Rs 27.51 Crore CENVAT Credit Refund Dispute, Tribunal Dismisses Revenue's Appeal

ITAT Remits Rs. 1.80 Crore Section 68 Addition for Fresh Verification of Accommodation Entries

ITAT Rules CBDT Monetary Limit of Rs.60 Lakh Applies Where Section 115BBE Is Inapplicable to Business Income

ITAT Dismisses Revenue and Assessee Appeals in Sahara Airlines Tax Dispute After IBC Proceedings

ITAT Dismisses Revenue Appeal in Section 153C Limitation Dispute

ITAT Dismisses Revenue Appeal in Section 153C Limitation Dispute